Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares ...

Super Micro Computer shares surged Wednesday after the company offered a strong sales outlook for 2026 on demand for AI ...

Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report ...

Wedbush raised their Q1 2025 earnings estimates for Uber Technologies in a report released on Wednesday, February 5th.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Shares of Roku (ROKU) closed lower in today’s trading as investors await its Q4 earnings results on February 13 after the ...

After reaching a net worth of more than $486 billion in December, Elon Musk’s wealth has sunk below $400 billion for the ...

Super Micro Computer (SMCI) came in below Street estimates in its fiscal second quarter and lowered its guidance for the full ...

AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.

Sahak Manuelian, managing director and head of equity trading at Wedbush, shares his reaction to the top winners and losers of the current earnings season.